Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: Enhancement by exercise-training

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 413-418

  Mombouli, Jean Vivien ^a   Nakashima, Mikio ^a   Hamra, Mary ^a   Vanhoutte, Paul M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin I converting enzyme; Endothelium derived hyperpolarizing factor; Kininase II; Kinins; N(G) nitro L arginine; Nitric oxide; Vascular smooth muscle

Indexed keywords

ARGININE DERIVATIVE; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; KININ; NITRIC OXIDE; PERINDOPRILAT; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DOG; ENZYME ACTIVITY; EXERCISE; HYPERPOLARIZATION; METABOLISM; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE TONE; VASCULAR ENDOTHELIUM;

EID: 0030022212     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15206.x     Document Type: Article

References (42)

1. ARCHER, S.L., HUANG, J.M.C., HAMPL, V., NELSON, D.P. & SHULTZ, P.J. (1994). Nitric oxide and cGMP cause vasorelaxation by cGMP-kinase-dependent activation of a charybdotoxin-sensitive K channel. Proc. Natl. Acad. Sci. U.S.A., 91, 7783-7787.
2. BENY, J.L. & VON DER WEID, P.Y. (1990). Hyperpolarizing factors. Coronary Art. Dis., 2, 300-306.
3. BLOMQUIST, C.G. & SALTIN, B. (1983). Cardiovascular adaptations to physical training. Annu. Rev. Physiol., 45, 169-189.
4. BOLOTINA, B.M., NAJIBI, S., PALACINO, J.J., PAGANO, P.G. & COHEN, R.A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, 368, 850-853.
5. CARRETERO, O.A. & SCICLI, A.G. (1991). Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension, 18 (Suppl I) 158-169.
6. CHERRY, P.D., FURCHGOTT, R.F., ZAWADSKI, J.V. & JOTHIANANDAN, D. (1982). Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc. Natl. Acad. Sci. U.S.A., 79, 2105-2110.
7. FELETOU, M. & VANHOUTTE, P.M. (1988). Endothelium-dependent hyperpolarisation of canine coronary smooth muscle. Br. J. Pharmacol., 93, 515-524.
8. FURCHGOTT, R.F. (1988). Studies on the relaxation of rabbit aorta by sodium nitrite. The basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis factor is inorganic nitrite and endothelium-derived relaxing factor is nitric oxide. In Vasodilation, ed. Vanhoutte, P.M. pp. 401-404. New York: Raven Press.
9. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J., 3, 2007-2018.
10. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 299, 373-376.
11. GARLAND, C.J., PLANE, F., KEMP, B.K. & COCKS, T.A. (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
12. HAMRA, M. & McNEIL, R.S. (1995). Cardiac adrenergic responses and electrophysiology during ischemia: effect of exercise. Med. Sci. Sport Exerc., 27, 993-1002.
13. IGNARRO, L.J., BUGA, G.M., BYRNS, R.E., WOOD, K.S. & CHAUDHURI, G. (1988). Endothelium-derived relaxing factor and nitric oxide posses identical pharmacologie properties as relaxants of bovine arterial and venous smooth muscle. J. Pharmacol. Exp. Ther., 246, 218-226.
14. ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol., 176, 219-223.
15. KAWAGUCHI, H., SAWA, H. & YASUDA, H. (1990). Mechanism of inceased angiotensin-converting enzyme activity stimulated by platelet-activating factor. Biochim. Biophys. Acta, 1052, 503-508.
16. KAWAGUCHI, H., SAW, H. & YASUDA, H. (1991). Effect of endothelin on angiotensin converting enzyme activity in cultured pulmonary artery endothelial cells. J. Hypertens., 9, 171-174.
17. KRULEWITZ, A.M. & FANBURG, B.L. (1986). Stimulation of bovine endothelial cell angiotensin-converting enzyme activity by cyclic AMP-related agents. J. Cell. Physiol., 129, 147-150.
18. LÜSCHER, T.F. & VANHOUTTE, P.M. (1990). The Encothelium: Modulator of Cardiovascular Function. Boca Raton, Fl. (USA): CRC press Inc.
19. MILLER, V.M. & VANHOUTTE, P.M. (1990). Enhanced release of endothelium-derived relaxing factor(s) by chronic increases in blood flow. Am. J. Physiol., 255, H446-H451.
20. MILLER, V.M., AARHUS, L.L. & VANHOUTTE, P.M. (1986). Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am. J. Physiol., 251, H520-H527.
21. MOMBOULI, J.V., ILLIANO, S., NAGAO, T., SCOTT-BURDEN, T. & VANHOUTTE, P.M (1992). The potentiation of endothelium-dependent relaxations to bradykinin in canine coronary arteries involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res., 71, 137-144.
22. MOMBOULI, J.V., NEPHTALI, M. & VANHOUTTE, P.M. (1991). Effects of the non-sulfhydryl angiotensin I converting enzyme inhibitor cilazaprilat on endothelium-dependent responses in isolated canine arteries. Hypertension, 18 (Suppl II), 1122-1129.
23. MOMBOULI, J.V. & VANHOUTTE, P.M. (1991). Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries. J. Cardiovasc. Pharmacol., 18, 926-927.
24. MOMBOULI, J.V. & VANHOUTTE, P.M. (1992). Heterogeneity of endothelium-dependent vasodilator effects of ACE-inhibitors: Role of bradykinin generation during ACE-inhibition. J. Cardiovasc. Pharmacol., 20 (Suppl 9), S74-S83.
25. MOMBOULI, J.V. & VANHOUTTE, P.M. (1995a). Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors. Am. J. Hypertens., 8, 19S-27S.
26. MOMBOULI, J.V. & VANHOUTTE, P.M. (1995b). Kinins and the regulation of vascular smooth muscle function by the endothelium. Annu. Rev. Pharmacol. Toxicol., 35, 679-705.
27. MONCADA, S., PALMER, R.H. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
28. MYERS, P.R., GUERRA, J.R. & HARRISSON, D.G. (1989). Release of NO and EDRF from cultured endothelial cells. Am. J. Physiol., 256, H1030-H1037.
29. NAGAO, T. & VANHOUTTE, P.M. (1992). Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J. Physiol., 445, 355-367.
30. OKABE, T., YAMAGATA, K., FUJISAWA, M., TAKAU, F., HIDAKA, H. & UMEZAWA, Y. (1987). Induction by fibroblast growth factor of angiotensin converting enzyme in vascular endothelial cells in vitro. Biochem. Biophys. Res. Commun., 145, 1211-1216.
31. OLTMAN, C.L., PARKER, J.L., ADAMS, H.R. & LAUGHLIN, M.H. (1992). Effects of exercise training on vasomotor reactivity of porcine coronary arteries. Am. J. Physiol., 263, H372-H382.
32. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 327, 524-526.
33. RETT, K., WICKLMAYR, M. & DIETZE, G.J. (1990). Metabolic effects of kinins: historical and recent developments. J. Cardiovasc. Pharmacol., 15 (Suppl. 6), S57-S59.
34. ROGERS, P.J., MILLER, T.D., BAUER, A., BRUM, J.M., BOVE, A.A. & VANHOUTTE, P.M. (1991). Exercise training and responsiveness of isolated coronary arteries. J. Appl. Physiol., 71, 2346-2351.
35. SESSA, W.C., PRITCHARD, K., SEYEDI, N., WANG, J. & HINTZE, T.H. (1994). Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res., 74, 349-353.
36. STONE, H.L. (1977). Cardiac function and exercise training in conscious dogs. J. Appl. Physiol., 42, 824-832.
37. STONE, H.L. (1983). Control of the coronary circulation during exercise. Annu. Rev. Physiol., 45, 213-227.
38. TATE, C., HAMRA, M., SHIN, G., TAFFET, G., MCBRIDE, P. & ENTMAN, M. (1993). Canine cardiac sarcoplasmic reticulum is not altered with endurance exercise training. Med. Sci. Sport and Exerc., 25, 1246-1257.
39. TIPTON, C.M., CAREY, R.A., EASTIN, W.C. & ERICKSON, H.H. (1974). A submaximal test for dogs: evaluation of effects of training, detraining, and cage confinement. J. Appl. Physiol., 37, 271-275.
40. TODA, N., BRIAN, K., AKIBA, T. & OKAMURA, H. (1987). Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels. Eur. J. Pharmacol., 135, 321-329.
41. WANG, J., WOLIN, M.S. & HINTZE, T.H. (1993). Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ. Res., 73, 829-838.
42. YANG, H., ERDÖS, E.G. & LEVIN, Y. (1970). A dipeptidyl carboxypeptidase that converts angiotensin and inactivates bradykinin. Biochem. Biophys. Acta, 214, 374-376.